Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography
상품코드:1741288
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
흉막 질환 시장은 2025년에는 57억 6,000만 달러로 평가되었고, 2032년에는 93억 7,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 7.2%를 나타낼 전망입니다.
보고 범위
보고서 세부 정보
기준 연도
2024년
2025년 시장 규모
57억 6,000만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
CAGR(2025-2032년)
7.20%
가치 예측(2032년)
93억 7,000만 달러
흉막 질환은 폐를 둘러싸고 있는 얇은 막인 흉막에 영향을 미치는 다양한 질환을 포함합니다. 이러한 질환은 호흡 기능과 전반적인 건강 상태에 심각한 영향을 미칠 수 있습니다. 흉막은 폐의 구조와 기능을 유지하는 데 중요한 역할을 하며, 호흡 시 윤활 작용을 제공하고 부드러운 움직임을 가능하게 합니다. 흉막 질환은 감염, 염증, 종양, 유해 물질 노출 등 다양한 원인으로 발생할 수 있습니다. 일반적인 흉막 질환에는 흉막염, 흉막 삼출, 기흉, 흉막 중피종이 포함됩니다. 증상을 인식하고 정확히 진단하며 적절한 치료 전략을 시행하는 것은 이러한 전 세계적으로 어려운 흉막 질환으로 고통받는 환자의 관리와 예후 개선에 필수적입니다. 전 세계 흉막 질환 시장은 흡연, 결핵, 전이 등 관련 위험 요인의 증가로 인해 최근 몇 년간 꾸준히 성장해 왔습니다. 또한 진단 및 치료 방법(영상 기술 및 레이저 치료 등) 분야의 기술적 진보가 시장 성장을 더욱 촉진하고 있습니다.
시장 역학 :
무기적 전략(협약 등)의 채택이 증가함에 따라 예측 기간 동안 시장 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2020년 11월, 제약 회사인 Taiho Pharmaceutical Co., Ltd.와 임상 단계 바이오제약 회사인 Lung Therapeutics, Inc.는 Lung Tx가 개발 중인 국소성 흉막 삼출액 치료를 위한 재조합 인간 단일 사슬 우로키나제 플라스미노겐 활성화제(LTI-01)에 대한 일본 지역 독점 라이선스 계약을 체결했습니다.
그러나 인식 부족과 진단 지연, 진단 도구 및 치료 비용, 전문 인력과 자원 부족은 예측 기간 동안 세계의 흉막 질환 시장 성장을 방해할 것으로 예상됩니다.
본 조사의 주요 특징
본 보고서는 세계의 흉막 질환 시장을 상세하게 분석하여 2024년을 기준 연도으로 한 예측기간 2025-2032년 시장 규모 및 연평균 성장률(CAGR)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 바탕으로 세계의 흉막 질환 시장의 주요 기업을 프로파일하고 있습니다.
이 보고서로부터의 통찰은 기업들의 마케팅 담당자와 경영진이 미래 제품 출시, 제품 업그레이드, 시장 확장, 마케팅 전략 등에 대한 정보 기반 결정을 내리는 데 도움을 줄 것입니다
세계의 흉막 질환 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계의 흉막 질환 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
일관된 기회 지도(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
성장 촉진요인
호흡기 질환의 이환율 증가
억제요인
전문 인력 및 자원 부족
기회
신규 바이오마커 및 정밀 의학의 등장
영향 분석
주요 하이라이트
규제 시나리오
제품 출시 및 승인
PEST 분석
PORTER 분석
합병과 인수 시나리오
제4장 세계의 흉막 질환 시장 : 코로나 바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급 측면 및 수요 측면 분석
경제에 미치는 영향
제5장 세계의 흉막 질환 시장 : 질환 유형별(2020-2032년)
흉막염
흉막 삼출
기흉
중피종
기타
제6장 세계의 흉막 질환 시장 : 진단 도구별(2020-2032년)
화상 기술
분자 진단
흉강경 및 흉막경 검사
제7장 세계의 흉막 질환 시장 : 치료법별(2020-2032년)
의약품
흉강천자 및 흉막고정술
최소 침습
수술
제8장 세계의 흉막 질환 시장 : 최종 사용자별(2020-2032년)
병원 및 진료소
진단센터
연구 및 학술 기관
제9장 세계의 흉막 질환 시장 : 지역별(2020-2032년)
북미
유럽
아시아태평양
라틴아메리카
중동
아프리카
제10장 경쟁 구도
Bristol Myers Squibb
Merck & Co., Inc.
GlaxoSmithKline plc
Boehringer Ingelheim International GmbH
Sanofi
AbbVie Inc.
Braun SE
Becton, Dickinson and Company
Bicakcilar
Biometrix
Cook Medical
Grena
Redax
Rocket Medical
Smith Medical
제11장 섹션
조사 방법
회사 소개
HBR
영문 목차
영문목차
Pleural Diseases Market is estimated to be valued at USD 5.76 Bn in 2025 and is expected to reach USD 9.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 5.76 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
7.20%
2032 Value Projection:
USD 9.37 Bn
Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The Global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.
Market Dynamics:
The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.
However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.
Key features of the study:
This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market
Global Pleural Diseases Market Segmentation Detailed Segmentation:
By Disease Types:
Pleurisy
Pleural Effusion
Pneumothelioma
Mesothelioma
Others
By Diagnostic Tools:
Imaging Techniques
Molecular Diagnostics
Thoracoscopy and Pleuroscopy
By Treatment Modalities:
Medications
Thoracentesis and Pleurodesis
Minimally Invasive Interventions
Surgical Interventions
By End User:
Hospitals and Clinics
Diagnostic Centers
Research and Academic Institutions
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profile:
Bristol Myers Squibb
Merck & Co., Inc.
GlaxoSmithKline plc
Boehringer Ingelheim International GmbH
Sanofi
AbbVie Inc.
Braun SE
Becton, Dickinson and Company
Bicakcilar
Biometrix
Cook Medical
Grena
Redax
Rocket Medical
Smith Medical
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Pleural Diseases, By Disease Type
Market Pleural Diseases, By Diagnostic Tools
Market Pleural Diseases, By Treatment Modalities
Market Pleural Diseases, By End User
Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing Prevalence of Respiratory diseases
Restraints
Limited Availability of Expertise and Resources
Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pleurisy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pleural Effusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pneumothelioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Mesothelioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Imaging Techniques
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 20218-2032, (US$ Billion)
Thoracoscopy and Pleuroscopy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Medications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Thoracentesis and Pleurodesis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Minimally Invasive Interventions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Surgical Interventions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Research and Academic Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Country 2021 -2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
